BioSpace News Archive

Business

Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2022 Financial Results

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Friday, February 3, 2023 at 8:30 a.m. ET.

January 6, 2023
·
1 min read
Business

Blueprint Medicines Appoints John Tsai, M.D. to its Board of Directors

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the appointment of John Tsai, M.D., to its board of directors.

January 6, 2023
·
7 min read
Genetown

Jnana Therapeutics Announces FDA Clearance of IND Application for JNT-517 for the Treatment of Phenylketonuria

Jnana Therapeutics today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for the clinical study of JNT-517 for the treatment of phenylketonuria (PKU).

January 6, 2023
·
3 min read
Business

AA Medical Announces Partnership with Certified Endoscopy Products

AA Medical is pleased to announce it has completed a partnership with Certified Endoscopy Products (“Certified Endoscopy” or “Certified”), a leading Chicago-based medical device reprocessing company specialized in endoscopic devices.

January 6, 2023
·
4 min read
Business

Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023

Bio-Rad Laboratories, Inc. will report its financial results for the fourth quarter and full year 2022 on Thursday, February 16, 2023, following the close of the market.

January 6, 2023
·
1 min read
BioMidwest

Keystone Bio to Present at the Sachs 6th Annual Neuroscience Innovation Forum

Keystone Bio announced today their participation as a keynote speaker at the Sachs 6th Annual Neuroscience Innovation Forum in San Francisco, CA.

January 6, 2023
·
1 min read